BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35489738)

  • 1. Prognostic Value of the Regional Lymph Node Station in Pancreatic Neuroendocrine Tumor.
    Takagi K; Umeda Y; Yoshida R; Yoshida K; Fuji T; Kumano K; Yasui K; Yagi T; Fujiwara T
    Anticancer Res; 2022 May; 42(5):2797-2801. PubMed ID: 35489738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of the Regional Lymph Node Station in Pancreatoduodenectomy for Ampullary Carcinoma.
    Takagi K; Nagai Y; Umeda Y; Yoshida R; Yoshida K; Fuji T; Kumano K; Yasui K; Yagi T; Fujiwara T
    In Vivo; 2022; 36(2):973-978. PubMed ID: 35241558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of lymph node metastasis in pancreatic neuroendocrine tumor.
    Taki K; Hashimoto D; Nakagawa S; Ozaki N; Tomiyasu S; Ohmuraya M; Arima K; Kaida T; Higashi T; Sakamoto K; Sakata K; Okabe H; Nitta H; Hayashi H; Chikamoto A; Beppu T; Takamori H; Hirota M; Baba H
    Surg Today; 2017 Sep; 47(9):1104-1110. PubMed ID: 28229300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconsidering the Optimal Regional Lymph Node Station According to Tumor Location for Pancreatic Cancer.
    Imamura T; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Ohgi K; Uesaka K
    Ann Surg Oncol; 2021 Mar; 28(3):1602-1611. PubMed ID: 32862372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.
    Lopez-Aguiar AG; Ethun CG; Zaidi MY; Rocha FG; Poultsides GA; Dillhoff M; Fields RC; Idrees K; Cho CS; Abbott DE; Cardona K; Maithel SK
    Surgery; 2019 Jul; 166(1):15-21. PubMed ID: 31072670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors.
    Zhang Z; Wang F; Li Z; Ye Z; Zhuo Q; Xu W; Liu W; Liu M; Fan G; Qin Y; Zhang Y; Chen X; Yu X; Xu X; Ji S
    BMC Surg; 2022 May; 22(1):160. PubMed ID: 35538535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysis.
    Wu L; Sahara K; Tsilimigras DI; Maithel SK; Poultsides GA; Rocha FG; Weber SM; Fields RC; Idrees K; Cho CS; Shen F; Pawlik TM;
    J Surg Oncol; 2019 Dec; 120(7):1080-1086. PubMed ID: 31468550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Factors of Small Non-Functional Pancreatic Neuroendocrine Tumors and the Risk of Lymph Node Metastasis: A Population-Level Study.
    Tan Q; Wang X; Li Y; Liu Y; Liu X; Ke N
    Front Endocrinol (Lausanne); 2022; 13():907415. PubMed ID: 35873006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas.
    Conrad C; Kutlu OC; Dasari A; Chan JA; Vauthey JN; Adams DB; Kim M; Fleming JB; Katz MH; Lee JE
    J Gastrointest Surg; 2016 Dec; 20(12):1966-1974. PubMed ID: 27714644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
    Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
    Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Site and Frequency of Lymph Node Metastasis with Non-Functioning Pancreatic Neuroendocrine Tumor.
    Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
    Eur Surg Res; 2019; 60(5-6):219-228. PubMed ID: 31734661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
    Parekh JR; Wang SC; Bergsland EK; Venook AP; Warren RS; Kim GE; Nakakura EK
    Pancreas; 2012 Aug; 41(6):840-4. PubMed ID: 22781907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.
    Sahara K; Tsilimigras DI; Mehta R; Moro A; Paredes AZ; Lopez-Aguiar AG; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Poultsides GA; Makris E; Cho C; Beems M; Dillhoff M; Maithel SK; Endo I; Pawlik TM
    Ann Surg Oncol; 2020 Apr; 27(4):1203-1212. PubMed ID: 31838609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node metastases and recurrence in pancreatic neuroendocrine neoplasms.
    Nießen A; Schimmack S; Lewosinska M; Hinz U; Bechtiger FA; Hackert T; Büchler MW; Strobel O
    Surgery; 2022 Dec; 172(6):1791-1799. PubMed ID: 36180252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of lymph node dissection for duodenal cancer according to the lymph node station.
    Miura Y; Ohgi K; Ashida R; Yamada M; Otsuka S; Sasaki K; Uesaka K; Sugiura T
    Ann Gastroenterol Surg; 2024 Jan; 8(1):51-59. PubMed ID: 38250683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.
    Poultsides GA; Huang LC; Chen Y; Visser BC; Pai RK; Jeffrey RB; Park WG; Chen AM; Kunz PL; Fisher GA; Norton JA
    Ann Surg Oncol; 2012 Jul; 19(7):2295-303. PubMed ID: 22396008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of Lymph Node Metastasis in Resectable Well-differentiated Pancreatic Neuroendocrine Tumor.
    Harimoto N; Hoshino K; Muranushi R; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Suzuki H; Arakawa K; Hirai K; Fukazawa T; Ikota H; Shirabe K
    Pancreas; 2019 Aug; 48(7):943-947. PubMed ID: 31268980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).
    Hashim YM; Trinkaus KM; Linehan DC; Strasberg SS; Fields RC; Cao D; Hawkins WG
    Ann Surg; 2014 Feb; 259(2):197-203. PubMed ID: 24253141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET.
    Lombardi M; De Lio N; Funel N; Sardella C; Russo D; Urbani C; Rossi G; Campani D; Martino E; Marcocci C; Boggi U; Bogazzi F
    J Endocrinol Invest; 2015 Jun; 38(6):605-13. PubMed ID: 25501604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.
    Tsutsumi K; Ohtsuka T; Mori Y; Fujino M; Yasui T; Aishima S; Takahata S; Nakamura M; Ito T; Tanaka M
    J Gastroenterol; 2012 Jun; 47(6):678-85. PubMed ID: 22350698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.